Svai Sanford is the Chief Financial Officer of Rani Therapeutics Holdings Inc. Mr. Sandford has more than 23 years of accounting, finance and management experience in the biopharmaceutical and medical device industries for both public and private companies. Prior to joining Rani, Mr. Sandford served as executive consultant and interim CFO for pH Pharma and Intuity Medical. Previously, Mr. Sandford held the position of CFO for SFJ Pharmaceuticals, a drug development company, and CFO and Chief Accounting Officer for VIVUS, Inc., a publicly traded, commercial-stage biopharmaceutical company. Mr. Sandford began his career with KPMG LLP, in its audit practice, where he earned his license as a certified public accountant. Mr. Sandford holds a B.S. degree with emphasis in accounting from Kansas State University.
Interview with the CEO and the CFO: Rani Therapeutics Holdings Inc. (NASDAQ:RANI)
November 17, 2022